Other News To Note
• Wuxi Pharmatech Inc., of Shanghai, said its wholly owned subsidiary entered a supply arrangement with Pharmacyclics Inc., of Sunnyvale, Calif., for Imbruvica (ibrutinib), the mantle-cell lymphoma therapy approved this month. Terms were not disclosed.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter